Brief: Novo Nordisk Completes Acquisition Of Akero Therapeutics
09/12/2025 13:53
Dec 9 (Reuters) - Novo Nordisk A/S NOVOb.CO: HAS COMPLETED ITS ACQUISITION OF AKERO THERAPEUTICS BUYS AKERO FOR $4.7 BILLION COMMON STOCK OF AKERO WILL NO LONGER BE LISTED OR TRADED ON NASDAQ GLOBAL SELECT MARKET Source text: ID:nGNE10F21w Further company coverage: [NOVOb.CO] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Akero Therapeutics
See all newsBrief: Novo Nordisk Completes Acquisition Of Akero Therapeutics
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Germany's Cartel Office Says It Approved Acquisition Of Akero Therapeutics By Novo Nordisk
Brief: Akero Therapeutics Stockholders Approve Acquisition By Novo Nordisk